Real-world evidence in safety assessment of new treatments

被引：7
|
作者：
Smedby, Karin E. [1 ,2 ]
Eloranta, Sandra [2 ]
机构：
[1] Karolinska Univ Hosp, Div Haematol, Dept Med Solna, S-17176 Stockholm, Sweden
[2] Karolinska Univ Hosp, Div Clin Epidemiol, Dept Med Solna, S-17176 Stockholm, Sweden
来源：
LANCET HAEMATOLOGY | 2018年 / 5卷 / 11期
关键词：
HODGKIN LYMPHOMA SURVIVORS; RELAPSE;
D O I：
10.1016/S2352-3026(18)30073-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E510 / E511
页数：2
相关论文
共 50 条
  • [1] Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
    Corrigan-Curay, Jacqueline
    Sacks, Leonard
    Woodcock, Janet
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (09): : 867 - 868
  • [2] A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of Treatments
    Winterstein, Almut G.
    Ehrenstein, Vera
    Brown, Jeffrey S.
    Stuermer, Til
    Smith, Meredith Y.
    DIABETES CARE, 2023, 46 (08) : 1448 - 1454
  • [3] When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?
    Simon, Gregory E.
    Platt, Richard
    Watanabe, Jonathan H.
    Bindman, Andrew B.
    John London, Alex
    Horberg, Michael
    Hernandez, Adrian
    Califf, Robert M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 30 - 34
  • [4] Real-world evidence for coverage determination of treatments for rare diseases
    Victoria W. Dayer
    Michael F. Drummond
    Omar Dabbous
    Mondher Toumi
    Peter Neumann
    Sean Tunis
    Nelson Teich
    Shadi Saleh
    Ulf Persson
    Johann-Matthias Graf von der Schulenburg
    Daniel C. Malone
    Tay Salimullah
    Sean D. Sullivan
    Orphanet Journal of Rare Diseases, 19
  • [5] Real-world evidence for coverage determination of treatments for rare diseases
    Dayer, Victoria W.
    Drummond, Michael F.
    Dabbous, Omar
    Toumi, Mondher
    Neumann, Peter
    Tunis, Sean
    Teich, Nelson
    Saleh, Shadi
    Persson, Ulf
    von der Schulenburg, Johann-Matthias Graf
    Malone, Daniel C.
    Salimullah, Tay
    Sullivan, Sean D.
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [6] Incretins and Diabetic Retinopathy: Real-World Evidence for Safety
    Wang, Tiansheng
    Gower, Emily
    Garg, Seema
    Pate, Virginia
    Buse, John
    Sturmer, Til
    Hong, Jin-Liern
    DIABETES, 2017, 66 : LB9 - LB9
  • [7] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [8] Leveraging Real-World Data in Safety Signal Assessment
    Patadia, Vaishali
    Manlik, Katrin
    Gipson, Geoffrey
    Willis, Jenna C.
    Namuyinga, Ruth
    Mcdermott, Rachel
    Shaw, Anita
    Miller, Mary K.
    Asubonteng, Julius
    Golchin, Negar
    von Klot, Stephanie
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (06) : 1062 - 1070
  • [9] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [10] Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments
    Schneeweiss, Sebastian
    Patorno, Elisabetta
    ENDOCRINE REVIEWS, 2021, 42 (05) : 658 - 690
12345